Advanced Serial Plasma Exchange Arrives in Beverly Hills as Los Angeles Faces Rising Environmental Health Concerns

Home / News / Advanced Serial Plasma Exchange Arrives in Beverly Hills as Los Angeles Faces Rising Environmental Health Concerns
MDLifespan Location Plasma Exchange Cenegenics Beverly Hills

Physician-led Advanced Therapeutic Plasma Exchange (TPE) protocols launch inside Cenegenics Beverly Hills, expanding access to personalized toxin reduction and biomarker-driven care in Southern California.

BEVERLY HILLS, CA (Feb. 27, 2026) – MDLifespan, a physician-led medical technology company and Public Benefit Corporation, today announced the launch of its Advanced Serial Therapeutic Plasma Exchange (TPE) protocols inside Cenegenics Beverly Hills.

The launch brings MDLifespan’s structured, multi-session Advanced Therapeutic Plasma Exchange protocols to the Los Angeles market through a clinical integration with Cenegenics Beverly Hills, a physician-led performance health center.

For patients and physicians searching for therapeutic plasma exchange in Beverly Hills, the new location provides access to MDLifespan’s physician-led approach to TPE, biomarker evaluation, and environmental toxin assessment.

Why Is Environmental Exposure a Growing Health Concern in Los Angeles?

Los Angeles residents encounter a range of environmental factors, including wildfire-related particulate matter, urban air pollution, and ongoing public-health discussions surrounding microplastics, PFAS, and other chemical contaminants.

As research continues to examine relationships between environmental exposures, inflammation, and health, some patients are seeking physician-directed strategies to better understand their individual exposure profiles and relevant biomarkers.

The Cenegenics Beverly Hills integration expands MDLifespan’s availability in Southern California and introduces its Advanced Serial Therapeutic Plasma Exchange protocols to the Los Angeles market.

“Southern California is a region where environmental exposure is part of the everyday health conversation,” said Dr. Paul Savage, Founder and Chief Medical Officer of MDLifespan. “Our Advanced Serial Plasma Exchange protocols are structured, physician-supervised plans designed to support measurable reductions in circulating inflammatory burden while integrating with advanced biomarker analysis.”

What Does Advanced Therapeutic Plasma Exchange Bring to Beverly Hills?

Through the integration, Cenegenics Beverly Hills patients have access to:

  • Multi-session, physician-led Advanced Serial Therapeutic Plasma Exchange protocols
  • Targeted diagnostics focused on environmental toxin exposure
  • Structured avoidance strategies designed to support reduction of ongoing environmental exposure
  • Biomarker tracking to evaluate changes over time
  • Physician oversight throughout the protocol process

 

Therapeutic Plasma Exchange has historically been used in hospital and specialty-care settings for specific medical indications. MDLifespan’s Advanced TPE model applies the established plasma-exchange procedure within a structured outpatient protocol framework focused on individualized evaluation and environmental exposure concerns.

Each protocol begins with diagnostic testing to assess relevant toxin markers and other biomarkers. Where appropriate, this is followed by a series of plasma exchange sessions and subsequent laboratory monitoring.

MDLifespan Cenegenics Beverly Hills Advanced Therapeutic Plasma Exchange

How Does MDLifespan Combine TPE With Biomarker Analysis?

The Beverly Hills launch reflects MDLifespan’s broader protocol-driven approach to Advanced TPE.

The model combines:

  • Precision biomarker analysis
  • Environmental toxin assessment
  • Multi-session Advanced TPE protocols
  • Ongoing physician oversight
  • Pre- and post-protocol laboratory monitoring, where appropriate

 

Rather than positioning plasma exchange as a single intervention, MDLifespan uses a structured protocol model designed to integrate with established physician-led clinical environments.

This approach allows physicians to consider laboratory data, environmental exposure information, patient history, and individual health goals when determining whether an Advanced TPE protocol is appropriate.

What Is the Difference Between Therapeutic Plasma Exchange and Advanced TPE?

Therapeutic Plasma Exchange is an established medical procedure involving the separation and replacement of plasma.

MDLifespan’s Advanced Therapeutic Plasma Exchange protocols build a structured, multi-session model around the procedure, incorporating physician oversight, individualized diagnostics, biomarker monitoring, and protocol-specific planning.

The approach is designed to support the evaluation and reduction of certain circulating substances while providing objective laboratory data that can be reviewed throughout the protocol.

Originally published via our press platform and republished in our official newsroom.

Expanding Access to Advanced TPE in Los Angeles

The Beverly Hills launch supports MDLifespan’s broader national expansion strategy, which centers on partnerships with established physician-led clinics and healthcare organizations.

The strategy includes:

  • Partnering with established physician-led clinical environments
  • Integrating Advanced TPE protocols into existing healthcare infrastructures
  • Delivering standardized, replicable protocol frameworks
  • Expanding geographic access to physician-led Advanced TPE
  • Supporting data-informed evaluation through biomarker monitoring

 

The addition of Beverly Hills gives patients and physicians in Los Angeles and surrounding Southern California communities another location through which to learn about MDLifespan’s Advanced TPE protocols.

Advanced Therapeutic Plasma Exchange in Beverly Hills

MDLifespan’s launch at Cenegenics Beverly Hills expands access to therapeutic plasma exchange in Beverly Hills while strengthening the organization’s presence in the Southern California market.

Patients and physicians interested in learning more about Advanced TPE, environmental toxin assessment, and the Beverly Hills location can explore MDLifespan’s educational resources or schedule a consultation.

To learn more or schedule a consultation, visit HERE

About MDLifespan

MDLifespan is a physician-led medical technology startup and certified Public Benefit Corporation delivering advanced detoxification and regenerative medicine solutions through Advanced Therapeutic Plasma Exchange. Founded by Dr. Paul Savage, MDLifespan focuses on removing environmental toxins and reversing chronic inflammation using clinically validated, personalized, and patented protocols.

About Cenegenics

Founded in 1997, Cenegenics is the global leader in performance health medicine and longevity. The company delivers personalized, physician-led programs grounded in comprehensive biomarker analysis, advanced diagnostics, evidence-based therapies, and continuous optimization.